Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Cognitive performance profiles by latent classes of drug use.

Harrell PT, Mancha BE, Martins SS, Mauro PM, Kuo JH, Scherer M, Bolla KI, Latimer WW.

Am J Addict. 2014 Sep-Oct;23(5):431-9. doi: 10.1111/j.1521-0391.2014.12124.x. Epub 2014 Mar 15.

2.

Cognitive dysfunctions in recreational and dependent cocaine users: role of attention-deficit hyperactivity disorder, craving and early age at onset.

Vonmoos M, Hulka LM, Preller KH, Jenni D, Baumgartner MR, Stohler R, Bolla KI, Quednow BB.

Br J Psychiatry. 2013 Jul;203(1):35-43. doi: 10.1192/bjp.bp.112.118091. Epub 2013 May 23.

3.

Cannabis use before age 15 and subsequent executive functioning.

Fontes MA, Bolla KI, Cunha PJ, Almeida PP, Jungerman F, Laranjeira RR, Bressan RA, Lacerda AL.

Br J Psychiatry. 2011 Jun;198(6):442-7. doi: 10.1192/bjp.bp.110.077479.

4.

Frontal Assessment Battery (FAB) is a simple tool for detecting executive deficits in chronic cannabis users.

Fontes MA, Bolla KI, Cunha PJ, Almeida PP, Jungerman F, Laranjeira RR, Bressan RA, Lacerda AL.

J Clin Exp Neuropsychol. 2011 Jun;33(5):523-31. doi: 10.1080/13803395.2010.535505. Epub 2011 Jan 10.

PMID:
21229432
5.

Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence.

Bolla KI, Lesage SR, Gamaldo CE, Neubauer DN, Wang NY, Funderburk FR, Allen RP, David PM, Cadet JL.

Sleep Med. 2010 Oct;11(9):882-9. doi: 10.1016/j.sleep.2010.02.013. Epub 2010 Aug 3.

6.

The frontal assessment battery (FAB) reveals neurocognitive dysfunction in substance-dependent individuals in distinct executive domains: Abstract reasoning, motor programming, and cognitive flexibility.

Cunha PJ, Nicastri S, de Andrade AG, Bolla KI.

Addict Behav. 2010 Oct;35(10):875-81. doi: 10.1016/j.addbeh.2010.05.005. Epub 2010 Jun 2.

PMID:
20584570
7.

Cumulative lead dose and cognitive function in older adults.

Bandeen-Roche K, Glass TA, Bolla KI, Todd AC, Schwartz BS.

Epidemiology. 2009 Nov;20(6):831-9. doi: 10.1097/EDE.0b013e3181b5f100.

8.

Neighborhood psychosocial hazards and the association of cumulative lead dose with cognitive function in older adults.

Glass TA, Bandeen-Roche K, McAtee M, Bolla K, Todd AC, Schwartz BS.

Am J Epidemiol. 2009 Mar 15;169(6):683-92. doi: 10.1093/aje/kwn390. Epub 2009 Jan 20.

9.

A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics.

Sano M, Jacobs D, Andrews H, Bell K, Graff-Radford N, Lucas J, Rabins P, Bolla K, Tsai WY, Cross P, Andrews K, Costa R, Xiaodong Luo.

Clin Trials. 2008;5(5):523-33. doi: 10.1177/1740774508096313.

10.

Apolipoprotein e genotype, cortisol, and cognitive function in community-dwelling older adults.

Lee BK, Glass TA, Wand GS, McAtee MJ, Bandeen-Roche K, Bolla KI, Schwartz BS.

Am J Psychiatry. 2008 Nov;165(11):1456-64. doi: 10.1176/appi.ajp.2008.07091532. Epub 2008 Jul 1.

11.

Sleep disturbance in heavy marijuana users.

Bolla KI, Lesage SR, Gamaldo CE, Neubauer DN, Funderburk FR, Cadet JL, David PM, Verdejo-Garcia A, Benbrook AR.

Sleep. 2008 Jun;31(6):901-8.

12.

Are brain volumes based on magnetic resonance imaging mediators of the associations of cumulative lead dose with cognitive function?

Caffo B, Chen S, Stewart W, Bolla K, Yousem D, Davatzikos C, Schwartz BS.

Am J Epidemiol. 2008 Feb 15;167(4):429-37. Epub 2007 Dec 12.

13.

Associations of salivary cortisol with cognitive function in the Baltimore memory study.

Lee BK, Glass TA, McAtee MJ, Wand GS, Bandeen-Roche K, Bolla KI, Schwartz BS.

Arch Gen Psychiatry. 2007 Jul;64(7):810-8.

PMID:
17606815
14.

Relations of brain volumes with cognitive function in males 45 years and older with past lead exposure.

Schwartz BS, Chen S, Caffo B, Stewart WF, Bolla KI, Yousem D, Davatzikos C.

Neuroimage. 2007 Aug 15;37(2):633-41. Epub 2007 Jun 2.

15.

Gender differences in neurocognitive functioning among alcohol-dependent Russian patients.

Flannery B, Fishbein D, Krupitsky E, Langevin D, Verbitskaya E, Bland C, Bolla K, Egorova V, Bushara N, Tsoy M, Zvartau E.

Alcohol Clin Exp Res. 2007 May;31(5):745-54. Epub 2007 Mar 26.

PMID:
17386068
16.

Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use.

Fishbein DH, Krupitsky E, Flannery BA, Langevin DJ, Bobashev G, Verbitskaya E, Augustine CB, Bolla KI, Zvartau E, Schech B, Egorova V, Bushara N, Tsoy M.

Drug Alcohol Depend. 2007 Sep 6;90(1):25-38. Epub 2007 Mar 26.

17.

The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task.

Verdejo-Garcia A, Benbrook A, Funderburk F, David P, Cadet JL, Bolla KI.

Drug Alcohol Depend. 2007 Sep 6;90(1):2-11. Epub 2007 Mar 23.

18.

Comparison of patella lead with blood lead and tibia lead and their associations with neurobehavioral test scores.

Dorsey CD, Lee BK, Bolla KI, Weaver VM, Lee SS, Lee GS, Todd AC, Shi W, Schwartz BS.

J Occup Environ Med. 2006 May;48(5):489-96.

PMID:
16688005
19.

Neurological assessments of marijuana users.

Cadet JL, Bolla K, Herning RI.

Methods Mol Med. 2006;123:255-68. Review.

PMID:
16506413
20.

Neural substrates of faulty decision-making in abstinent marijuana users.

Bolla KI, Eldreth DA, Matochik JA, Cadet JL.

Neuroimage. 2005 Jun;26(2):480-92. Epub 2005 Mar 23.

PMID:
15907305

Supplemental Content

Loading ...
Support Center